JCI Insight (Apr 2022)

Oxidative stress promotes fibrosis in systemic sclerosis through stabilization of a kinase-phosphatase complex

  • Ruiyuan Zhang,
  • Ganesan Senthil Kumar,
  • Uwe Hansen,
  • Martina Zoccheddu,
  • Cristiano Sacchetti,
  • Zachary J. Holmes,
  • Megan C. Lee,
  • Denise Beckmann,
  • Yutao Wen,
  • Zbigniew Mikulski,
  • Shen Yang,
  • Eugenio Santelli,
  • Rebecca Page,
  • Francesco Boin,
  • Wolfgang Peti,
  • Nunzio Bottini

Journal volume & issue
Vol. 7, no. 8

Abstract

Read online

Systemic sclerosis (SSc) is a fibrotic autoimmune disease characterized by pathogenic activation of fibroblasts enhanced by local oxidative stress. The tyrosine phosphatase PTP4A1 was identified as a critical promoter of TGF-β signaling in SSc. Oxidative stress is known to functionally inactivate tyrosine phosphatases. Here, we assessed whether oxidation of PTP4A1 modulates its profibrotic action and found that PTP4A1 forms a complex with the kinase SRC in scleroderma fibroblasts, but surprisingly, oxidative stress enhanced rather than reduced PTP4A1’s association with SRC and its profibrotic action. Through structural assessment of the oxo-PTP4A1-SRC complex, we unraveled an unexpected mechanism whereby oxidation of a tyrosine phosphatase promotes its function through modification of its protein complex. Considering the importance of oxidative stress in the pathogenesis of SSc and fibrosis, our findings suggest routes for leveraging PTP4A1 oxidation as a potential strategy for developing antifibrotic agents.

Keywords